We have a wide range of approved products by all leading brands in the world
GLP-1 receptor agonists may be considered when additional treatment goals include weight reduction, improved glycemic control, chronic kidney disease risk reduction, or lowering atherosclerotic cardiovascular risk, particularly in patients with obesity or established Atherosclerotic Cardiovascular Disease (ASCVD) [7, 16, 47]
For more on this, read Fibermaxxing for Weight Loss
Hydration becomes important : With reduced food intake and slower digestion, dehydration is a real risk
Thats a huge perk for those who arent comfortable with injections, says Ho
Endocrinology 160:16451658